Who is sponsoring NCT01012999?

NCT01012999 is sponsored by University of Utah.

What condition does NCT01012999 study?

NCT01012999 studies Pain, Opiate.

What is the status of NCT01012999?

NCT01012999 is currently TERMINATED.

Last reviewed 2017-06-21 · How we verify

Pain Control and Patient Satisfaction: a Dosing Study to Determine a Safe and Effective Dose of Intra-nasal Sufentanil to Treat Emergency Department Patients With Moderate to Severe Pain Due to Extremity Trauma

NCT01012999 Phase 1/Phase 2 TERMINATED Results posted

The purpose of this study is to determine the appropriate dose and effectiveness of intra-nasal administration of a potent narcotic, sufentanil, for the treatment of moderate to severe pain due to broken bone(s) in the arm or leg.

Details

Lead sponsor	University of Utah
Phase	Phase 1/Phase 2
Status	TERMINATED
Enrolment	16
Start date	2009-11
Completion	2011-03

Conditions

Pain
Opiate

Interventions

sufentanil

Primary outcomes

Pain Relief at Thirty Minutes — 30 min post dose
Measured pain relief on a visual analog scale (0-10- ten being the worst pain and zero being no pain at all).

Countries

United States